Related references
Note: Only part of the references are listed.Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites
Xiang Zhang et al.
GUT (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Hepatokines and adipokines in NASH-related hepatocellular carcinoma
Ozlem Kucukoglu et al.
JOURNAL OF HEPATOLOGY (2021)
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores
Cristiana Bianco et al.
JOURNAL OF HEPATOLOGY (2021)
Increased Visceral Adipose Tissue and Hyperinsulinemia Raise the Risk for Recurrence of Non-B Non-C Hepatocellular Carcinoma after Curative Treatment
Kenji Imai et al.
CANCERS (2021)
Nonalcoholic Steatohepatitis Is Associated With Liver-Related Outcomes and All-Cause Mortality in Chronic Hepatitis B
Hannah S. J. Choi et al.
HEPATOLOGY (2020)
Correlates of alcohol consumption and alcohol dependence among older adults in contemporary China: Results from the Chinese Longitudinal Healthy Longevity Survey
Yen-Han Lee et al.
JOURNAL OF ETHNICITY IN SUBSTANCE ABUSE (2020)
Modelling NAFLD disease burden in four Asian regions-2019-2030
Chris Estes et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma
Bruno Sangro et al.
JOURNAL OF HEPATOLOGY (2020)
Liver stiffness measurement predicts long-term survival and complications in non-alcoholic fatty liver disease
Sarah Shili-Masmoudi et al.
LIVER INTERNATIONAL (2020)
Positive Hepatitis B Core Antibody Is Associated With Cirrhosis and Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
Ting Ting Chan et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2020)
Global Burden of 5 Major Types of Gastrointestinal Cancer
Melina Arnold et al.
GASTROENTEROLOGY (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Unhealthy lifestyle habits and physical inactivity among Asian patients with non-alcoholic fatty liver disease
Xinrong Zhang et al.
LIVER INTERNATIONAL (2020)
Aflatoxin B1: A review on metabolism, toxicity, occurrence in food, occupational exposure, and detoxification methods
Blake R. Rushing et al.
FOOD AND CHEMICAL TOXICOLOGY (2019)
Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosis
Kazuhisa Kodama et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2019)
Rising rural body-mass index is the main driver of the global obesity epidemic in adults
Honor Bixby et al.
NATURE (2019)
Physical Activity and the Risk of Liver Cancer: A Systematic Review and Meta-Analysis of Prospective Studies and a Bias Analysis
Sebastian E. Baumeister et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2019)
Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019: a systematic review and meta-analysis
Jie Li et al.
LANCET GASTROENTEROLOGY & HEPATOLOGY (2019)
Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver Disease
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Unified interpretation of liver stiffness measurement by M and XL probes in non-alcoholic fatty liver disease
Vincent Wai-Sun Wong et al.
GUT (2019)
A nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update
Ryosuke Tateishi et al.
JOURNAL OF GASTROENTEROLOGY (2019)
Genetics and epigenetics of NAFLD and NASH: Clinical impact
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2018)
Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030
Chris Estes et al.
JOURNAL OF HEPATOLOGY (2018)
Development of a scoring system to predict hepatocellular carcinoma in Asians on antivirals for chronic hepatitis B
Yao-Chun Hsu et al.
JOURNAL OF HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Increasing Burden of Liver Cancer Despite Extensive Use of Antiviral Agents in a Hepatitis B Virus-Endemic Population
Jonggi Choi et al.
HEPATOLOGY (2017)
The Membrane-Bound O-Acyltransferase Domain-Containing 7 Variant rs641738 Increases Inflammation and Fibrosis in Chronic Hepatitis B
Khaled Thabet et al.
HEPATOLOGY (2017)
Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B
Anthony W. H. Chan et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2017)
Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
Jordi Bruix et al.
JOURNAL OF HEPATOLOGY (2017)
New trends on obesity and NAFLD in Asia
Jian-Gao Fan et al.
JOURNAL OF HEPATOLOGY (2017)
Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia
Alvin W. T. Ng et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Diabetes in Asia and the Pacific: Implications for the Global Epidemic
Arun Nanditha et al.
DIABETES CARE (2016)
Association of Nonalcoholic Fatty Liver Disease (NAFLD) with Hepatocellular Carcinoma (HCC) in the United States From 2004 to 2009
Zobair M. Younossi et al.
HEPATOLOGY (2015)
Expanding consensus in portal hypertension Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension
Roberto de Franchis
JOURNAL OF HEPATOLOGY (2015)
Diet-Quality Scores and Prevalence of Nonalcoholic Fatty Liver Disease: A Population Study Using Proton-Magnetic Resonance Spectroscopy
Ruth Chan et al.
PLOS ONE (2015)
PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome
J. Shen et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Prevalence of the TM6SF2 variant and non-alcoholic fatty liver disease in Chinese
Vincent Wai-Sun Wong et al.
JOURNAL OF HEPATOLOGY (2014)
Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study
Patrick Marcellin et al.
LANCET (2013)
Risk of Hepatocellular Carcinoma in Diabetic Patients and Risk Reduction Associated With Anti-Diabetic Therapy: A Population-Based Cohort Study
Shih-Wei Lai et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Large-Scale Long-Term Follow-Up Study of Japanese Patients With Non-Alcoholic Fatty Liver Disease for the Onset of Hepatocellular Carcinoma
Yusuke Kawamura et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Excess body weight and the risk of primary liver cancer: An updated meta-analysis of prospective studies
Yi Chen et al.
EUROPEAN JOURNAL OF CANCER (2012)
Relative Etiological Role of Prior Hepatitis B Virus Infection and Nonalcoholic Fatty Liver Disease in the Development of Non-B Non-C Hepatocellular Carcinoma in a Hepatitis B-Endemic Area
Eun Ju Cho et al.
DIGESTION (2011)
Association of Diabetes Duration and Diabetes Treatment With the Risk of Hepatocellular Carcinoma
Manal M. Hassan et al.
CANCER (2010)
Hepatic steatosis is a risk factor for postoperative complications after major hepatectomy - A matched case-control study
Lucas McCormack et al.
ANNALS OF SURGERY (2007)
Share Paper
